Ce document numérisé est le fruit d'un long travail approuvé par le ...

175
12. Assmus H, Thiele RM : Gibt es extrem ehronisehe Ver laufe bei der
myatrophisehen lateralskerlose ? Nevvenarzt 1973; 44 : 609-610.
13. Barde B. Trophie factors and neuronal survival. Neuron 1989; 2: 1525-1534.
14. Beal MF. Role of excitotoxicity in human neurological disease. Curr Opin
Neurobiol 1993; 2 : 657-662.
15. BeaI MF, Hyman BT, Koroshétz W. Do defects in mitoehondrial energy
metabolism underlie the pathology of neurodegenerative disease ? Trends
N eurosci 1993; 16 : 125-131.
16. Beekman JS, Chen J, Crow JP, Ye YZ. Reactions of nitrie oxide, superoxide
and peroxynitrite with superoxide dismutase in neurodegeneration. Prog Brain
Res 1994; 103 : 371-380.
17. Ben Hamida M, Hentati F, Ben Hamida C. Hereditary motor system disease
(ehronie juvenile amyotrophie lateral sclerosis). Brain 1990; 113 : 347-363.
18. Bensimon G, Laeomblez L, Meininger V, and the ALS / Riluzole Study
Group. A eontrolled trial of riluzole in amyotrophie lateral sclerosis. N. Engl J
1994; 330: 585-591.
19. Bergeron C, Beric-Maskarel K, Muntasser S, et al. Neurofilament light and
polyadenylated in RNA levels are deereased in amyotrophie lateral sclerosis
motor neurons. J. Neuropathol Exp. Neurol 1994; 53: 221-230.
20. Bergeron C, Muntasser S, Somerville MI, et aL Copper zinc superoxide
dismutase nRNA levels are inereased in sporadie amyotrophie lateral sclerosis
motor neurons. Brain Res 1994; 659: 272-276.
21. Bharueha NE, Schoenberg BS, Raven RH, et aL Geographie distribution of
motor neuron disease and correlation with possible etiologie factor. Neurology
1983; 33: 911-915.
22. Bodowiek AR, Brody JA. Epidemiology of motor neuron diseases. N. EngL J.
Med 1973; 288: 1047-1055.
23. Bonduelle M. Amyotrophie lateral sclerosis. Handb Clin NeuroL 1975; 22 :
281-338.
24. Boothby JA, de Jesus PV, Rowland LP. Reversible forms of motor neuron
disease. Lead "neuritis". Arch Neurol 1974; 31 : 18-23.